EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS

• المؤلفون الرئيسيون: L. A. Balykova (مؤلف), O. A. Radaeva (مؤلف), K. Ya. Zaslavskaya (مؤلف), P. A. Bely (مؤلف), V. F. Pavelkina (مؤلف), N. A. Pyataev (مؤلف), A. Yu. Ivanova (مؤلف), G. V. Rodoman (مؤلف), N. E. Kostina (مؤلف), V. B. Filimonov (مؤلف), E. N. Simakina (مؤلف), D. A. Bystritsky (مؤلف), A. S. Agafyina (مؤلف), K. N. Koryanova (مؤلف), D. Yu. Pushkar (مؤلف)
• التنسيق: كتاب
• منشور في: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2023-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Currently, there are data that that make it possible to speak about a high clinical efficacy of the use of succinic salt of tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine (hexapeptide succinate) for the COVID-19 treatment. This article is devoted to the results of clinical trials of the origin...